Skip to main content

Molina Healthcare Announces First Quarter 2023 Earnings Release and Conference Call Dates and Virtual Investor Day Meeting

Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ending March 31, 2023.

Molina Healthcare will issue its earnings release for the first quarter ending March 31, 2023, after the market closes on Wednesday, April 26, 2023, and will host a conference call and webcast to discuss the earnings release on Thursday, April 27, 2023, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 1543593. A telephonic replay of the conference call will be available through Thursday, May 4, 2023, by dialing (877) 344-7529 and entering the confirmation number, 5745408.

A live broadcast of Molina Healthcare’s conference call will be available on the Company’s website, molinahealthcare.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast.

2023 Virtual Investor Day

The Company also announced it will host a Virtual Investor Day meeting on Monday, May 15, 2023, beginning at 8:30 a.m. Eastern Time.

Investors can register for the event at www.molinahealthcareinvestorday.com/2023.

A 30-day online replay of the Investor Day meeting will be available approximately one hour following the conclusion of the live webcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company (currently ranked 125), provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 5.3 million members as of December 31, 2022. For more information about Molina Healthcare, please visit molinahealthcare.com.

Contacts

Investor Contact: Joseph Krocheski, 562-951-8382

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.